Safety and Immunogenicity of a Tetravalent Live-Attenuated Dengue Vaccine in Flavivirus-Naive Infants

A Phase I/II observer-blind, randomized, controlled trial evaluated the safety and immunogenicity of a dengue virus (DENV) vaccine candidate in healthy Thai infants (aged 12–15 months) without measurable pre-vaccination neutralizing antibodies to DENV and Japanese encephalitis virus. Fifty-one subje...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Watanaveeradej, Veerachai, Simasathien, Sriluck, Nisalak, Ananda, Endy, Timothy P., Jarman, Richard G., Innis, Bruce L., Thomas, Stephen J., Gibbons, Robert V., Hengprasert, Sumetha, Samakoses, Rudiwilai, Kerdpanich, Angkool, Vaughn, David W., Putnak, J. Robert, Eckels, Kenneth H., Barrera, Rafael De La, Mammen, Mammen P.
Formato: Artigo
Idioma:Inglês
Publicado em: The American Society of Tropical Medicine and Hygiene 2011
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3144835/
https://ncbi.nlm.nih.gov/pubmed/21813857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4269/ajtmh.2011.10-0501
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados